3 withdrawn. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Withdrawn 3 |
| Phase 2 | 1 | Withdrawn 1 |
Follow ADHD: new trials by email Literature Review of ADHD trials Research Report on ADHD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effectiveness of a Digital Strategy-based Educational Skills Group for Secondary Students With Organization and Academic Motivation Challenges BPT/OST, Peer Support - ADHD | Phase 2 / Phase 3 | Withdrawn | Seattle Children's Hospital | 2022-05-18 | 2026-04-24 | |
| Classroom Study of SPN-812 in Children With ADHD Placebo, 200 mg SPN-812 - ADHD | Phase 3 | Withdrawn | Supernus Pharmaceuticals, Inc. | 2019-08-01 | 2019-09-18 | |
| Safety and Efficacy of SPD489 in Adolescent Subjects Aged 13-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD) SPD489, Placebo - ADHD | Phase 3 | Withdrawn | Shire | 2011-03-06 | 2021-06-03 |
Attention Deficit Disorder with Hyperactivity (3)
Attention Deficit and Disruptive Behavior Disorders (3) · Mental Disorders (3) · Neurodevelopmental Disorders (3)
Lisdexamfetamine Dimesylate (1)
Seattle Children's Hospital (1) · Shire (1) · Supernus Pharmaceuticals, Inc. (1)
United States (1)